Gene Symbol | Gene ID | Gene Info |
---|---|---|
SOX14
|
ENSG00000168875.1 | SRY-box transcription factor 14 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr3_137490436_137490587 | SOX14 | 6932 | 0.322540 | -0.82 | 6.8e-03 | Click! |
chr3_137489915_137490161 | SOX14 | 6459 | 0.325938 | 0.50 | 1.8e-01 | Click! |
chr3_137489277_137489428 | SOX14 | 5773 | 0.332039 | 0.47 | 2.0e-01 | Click! |
chr3_137486919_137487668 | SOX14 | 3714 | 0.369142 | 0.47 | 2.0e-01 | Click! |
chr3_137489599_137489750 | SOX14 | 6095 | 0.328971 | -0.26 | 4.9e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr7_117512754_117513170 | 0.64 |
CTTNBP2 |
cortactin binding protein 2 |
599 |
0.85 |
chr13_93879365_93880233 | 0.62 |
GPC6 |
glypican 6 |
704 |
0.82 |
chr12_64239539_64239880 | 0.58 |
SRGAP1 |
SLIT-ROBO Rho GTPase activating protein 1 |
1168 |
0.42 |
chr2_38303069_38303895 | 0.55 |
CYP1B1-AS1 |
CYP1B1 antisense RNA 1 |
156 |
0.5 |
chr21_17442706_17442989 | 0.51 |
ENSG00000252273 |
. |
35018 |
0.24 |
chr10_30138566_30138997 | 0.50 |
SVIL |
supervillin |
114048 |
0.06 |
chr12_27398836_27399341 | 0.48 |
STK38L |
serine/threonine kinase 38 like |
498 |
0.86 |
chr1_162603392_162603656 | 0.48 |
DDR2 |
discoidin domain receptor tyrosine kinase 2 |
1264 |
0.48 |
chr2_3223937_3224088 | 0.47 |
TSSC1-IT1 |
TSSC1 intronic transcript 1 (non-protein coding) |
81224 |
0.1 |
chr5_169407172_169407407 | 0.43 |
FAM196B |
family with sequence similarity 196, member B |
455 |
0.87 |
chr2_159825200_159826543 | 0.43 |
TANC1 |
tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 |
688 |
0.73 |
chr22_46471692_46472277 | 0.42 |
FLJ27365 |
hsa-mir-4763 |
4208 |
0.11 |
chr17_39861478_39861907 | 0.41 |
GAST |
gastrin |
6886 |
0.1 |
chr4_184276450_184276660 | 0.41 |
ENSG00000238596 |
. |
26104 |
0.12 |
chr10_102110957_102111108 | 0.40 |
SCD |
stearoyl-CoA desaturase (delta-9-desaturase) |
4151 |
0.16 |
chr5_174178214_174178699 | 0.39 |
ENSG00000266890 |
. |
281 |
0.94 |
chr10_95196659_95197038 | 0.39 |
MYOF |
myoferlin |
45103 |
0.14 |
chr18_31157392_31158104 | 0.38 |
ASXL3 |
additional sex combs like 3 (Drosophila) |
848 |
0.76 |
chr15_92937263_92937484 | 0.38 |
ST8SIA2 |
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2 |
78 |
0.98 |
chr3_114404388_114404544 | 0.38 |
ENSG00000264623 |
. |
57906 |
0.14 |
chr6_55956266_55956474 | 0.37 |
COL21A1 |
collagen, type XXI, alpha 1 |
13468 |
0.31 |
chr8_71359441_71359951 | 0.37 |
ENSG00000253143 |
. |
33026 |
0.17 |
chr6_166074004_166074283 | 0.36 |
PDE10A |
phosphodiesterase 10A |
1414 |
0.55 |
chr2_11990210_11990442 | 0.36 |
ENSG00000265172 |
. |
13214 |
0.21 |
chr2_51180015_51180298 | 0.36 |
ENSG00000272385 |
. |
8227 |
0.23 |
chr9_127024548_127024933 | 0.36 |
RP11-121A14.3 |
|
415 |
0.67 |
chr7_93552832_93552983 | 0.35 |
GNG11 |
guanine nucleotide binding protein (G protein), gamma 11 |
1896 |
0.3 |
chr17_42440424_42441259 | 0.35 |
FAM171A2 |
family with sequence similarity 171, member A2 |
402 |
0.73 |
chr3_140329223_140329374 | 0.35 |
TRIM42 |
tripartite motif containing 42 |
67583 |
0.12 |
chr13_45008185_45008336 | 0.35 |
TSC22D1 |
TSC22 domain family, member 1 |
2721 |
0.38 |
chr6_150176715_150177267 | 0.34 |
RP11-350J20.12 |
|
3393 |
0.15 |
chr17_39941723_39942672 | 0.34 |
JUP |
junction plakoglobin |
125 |
0.93 |
chrX_102611721_102612532 | 0.34 |
WBP5 |
WW domain binding protein 5 |
746 |
0.61 |
chr4_420426_420577 | 0.34 |
ENSG00000211482 |
. |
16903 |
0.16 |
chrX_10547580_10547808 | 0.34 |
MID1 |
midline 1 (Opitz/BBB syndrome) |
2699 |
0.31 |
chr4_141015619_141015856 | 0.34 |
RP11-392B6.1 |
|
33432 |
0.2 |
chr5_133846660_133846957 | 0.33 |
ENSG00000240250 |
. |
6693 |
0.16 |
chr18_56244442_56244608 | 0.33 |
RP11-126O1.2 |
|
20223 |
0.14 |
chr2_36704404_36704701 | 0.33 |
CRIM1 |
cysteine rich transmembrane BMP regulator 1 (chordin-like) |
36281 |
0.17 |
chr19_9517131_9518356 | 0.33 |
ZNF266 |
zinc finger protein 266 |
12014 |
0.16 |
chr19_43025793_43025944 | 0.32 |
CEACAM1 |
carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein) |
6106 |
0.18 |
chr10_73608410_73608759 | 0.32 |
PSAP |
prosaposin |
2498 |
0.27 |
chr9_89952337_89952906 | 0.32 |
ENSG00000212421 |
. |
77256 |
0.11 |
chr19_34359259_34359976 | 0.32 |
ENSG00000240626 |
. |
58913 |
0.13 |
chr19_41195400_41196566 | 0.32 |
NUMBL |
numb homolog (Drosophila)-like |
44 |
0.96 |
chr1_33812503_33812654 | 0.31 |
PHC2 |
polyhomeotic homolog 2 (Drosophila) |
2908 |
0.16 |
chr4_54459304_54459510 | 0.31 |
LNX1-AS2 |
LNX1 antisense RNA 2 |
255 |
0.9 |
chr2_165924520_165924997 | 0.31 |
SCN3A |
sodium channel, voltage-gated, type III, alpha subunit |
25580 |
0.2 |
chr7_112725821_112726406 | 0.31 |
GPR85 |
G protein-coupled receptor 85 |
280 |
0.92 |
chr6_128812548_128813040 | 0.30 |
RP1-86D1.5 |
|
8878 |
0.17 |
chr5_148786834_148787025 | 0.29 |
ENSG00000208035 |
. |
21552 |
0.11 |
chr6_160015485_160015820 | 0.29 |
SOD2 |
superoxide dismutase 2, mitochondrial |
98608 |
0.07 |
chr5_82768204_82768925 | 0.29 |
VCAN |
versican |
820 |
0.75 |
chr6_72129322_72130506 | 0.29 |
ENSG00000207827 |
. |
16590 |
0.22 |
chr4_146403033_146403938 | 0.29 |
SMAD1 |
SMAD family member 1 |
153 |
0.96 |
chr9_124888898_124889336 | 0.29 |
ENSG00000266583 |
. |
6671 |
0.17 |
chr17_13240957_13241216 | 0.29 |
ENSG00000266115 |
. |
162559 |
0.04 |
chr9_13278507_13279169 | 0.29 |
RP11-272P10.2 |
|
348 |
0.67 |
chrX_38079311_38080259 | 0.29 |
SRPX |
sushi-repeat containing protein, X-linked |
367 |
0.75 |
chr9_103113243_103113394 | 0.29 |
TEX10 |
testis expressed 10 |
1535 |
0.45 |
chr13_38443188_38443573 | 0.28 |
TRPC4 |
transient receptor potential cation channel, subfamily C, member 4 |
480 |
0.86 |
chr11_92361716_92361867 | 0.28 |
ENSG00000239086 |
. |
100790 |
0.08 |
chr4_139939633_139940037 | 0.28 |
ENSG00000264953 |
. |
1102 |
0.42 |
chr20_3386904_3388207 | 0.28 |
C20orf194 |
chromosome 20 open reading frame 194 |
717 |
0.59 |
chr3_12879915_12880160 | 0.28 |
ENSG00000207496 |
. |
1912 |
0.22 |
chr4_140925773_140926068 | 0.27 |
MAML3 |
mastermind-like 3 (Drosophila) |
113799 |
0.06 |
chr1_61598470_61598652 | 0.27 |
RP4-802A10.1 |
|
8156 |
0.25 |
chr5_105791072_105791223 | 0.27 |
ENSG00000252337 |
. |
91219 |
0.1 |
chr15_48894702_48894960 | 0.27 |
FBN1 |
fibrillin 1 |
43087 |
0.18 |
chr4_146467680_146467914 | 0.27 |
SMAD1-AS1 |
SMAD1 antisense RNA 1 |
29527 |
0.16 |
chr3_112358713_112358917 | 0.27 |
CCDC80 |
coiled-coil domain containing 80 |
1301 |
0.54 |
chr11_122049732_122050124 | 0.27 |
ENSG00000207994 |
. |
26912 |
0.16 |
chr1_225839301_225840394 | 0.27 |
ENAH |
enabled homolog (Drosophila) |
571 |
0.78 |
chr3_185482470_185482728 | 0.27 |
ENSG00000265470 |
. |
3093 |
0.3 |
chrX_102940107_102940387 | 0.26 |
MORF4L2 |
mortality factor 4 like 2 |
902 |
0.43 |
chr5_14441548_14441780 | 0.26 |
TRIO |
trio Rho guanine nucleotide exchange factor |
46893 |
0.19 |
chr20_1876393_1876635 | 0.26 |
SIRPA |
signal-regulatory protein alpha |
572 |
0.81 |
chr12_54569137_54569288 | 0.26 |
RP11-834C11.8 |
|
12289 |
0.11 |
chr13_41114829_41114980 | 0.26 |
AL133318.1 |
Uncharacterized protein |
3581 |
0.34 |
chr1_228277450_228277698 | 0.26 |
ARF1 |
ADP-ribosylation factor 1 |
6723 |
0.12 |
chr2_216299709_216300678 | 0.26 |
FN1 |
fibronectin 1 |
597 |
0.55 |
chr19_56989540_56990106 | 0.26 |
ZNF667 |
zinc finger protein 667 |
389 |
0.8 |
chr2_5866291_5866487 | 0.25 |
SOX11 |
SRY (sex determining region Y)-box 11 |
33590 |
0.17 |
chr4_77873265_77873416 | 0.25 |
SEPT11 |
septin 11 |
2325 |
0.36 |
chr2_45834098_45834249 | 0.25 |
SRBD1 |
S1 RNA binding domain 1 |
4247 |
0.26 |
chr1_120189851_120190681 | 0.25 |
ZNF697 |
zinc finger protein 697 |
130 |
0.97 |
chr13_30250925_30251280 | 0.25 |
SLC7A1 |
solute carrier family 7 (cationic amino acid transporter, y+ system), member 1 |
81277 |
0.11 |
chr12_133137038_133137885 | 0.25 |
P2RX2 |
purinergic receptor P2X, ligand-gated ion channel, 2 |
57905 |
0.1 |
chr8_107067814_107067965 | 0.25 |
ENSG00000251003 |
. |
4782 |
0.34 |
chr1_31380173_31380807 | 0.25 |
SDC3 |
syndecan 3 |
1118 |
0.44 |
chr6_123316934_123317301 | 0.25 |
CLVS2 |
clavesin 2 |
1 |
0.99 |
chr11_131780761_131781452 | 0.25 |
NTM |
neurotrimin |
209 |
0.95 |
chr2_122241860_122242011 | 0.25 |
CLASP1 |
cytoplasmic linker associated protein 1 |
5969 |
0.24 |
chr3_134089254_134089458 | 0.25 |
AMOTL2 |
angiomotin like 2 |
1398 |
0.47 |
chr2_71127433_71128165 | 0.25 |
VAX2 |
ventral anterior homeobox 2 |
79 |
0.96 |
chr22_36232318_36232521 | 0.25 |
RBFOX2 |
RNA binding protein, fox-1 homolog (C. elegans) 2 |
3846 |
0.33 |
chr20_50063008_50063250 | 0.25 |
ENSG00000266761 |
. |
6385 |
0.28 |
chr2_106260790_106261225 | 0.24 |
NCK2 |
NCK adaptor protein 2 |
100347 |
0.08 |
chr5_33936276_33936635 | 0.24 |
RXFP3 |
relaxin/insulin-like family peptide receptor 3 |
36 |
0.98 |
chr15_92404681_92404832 | 0.24 |
SLCO3A1 |
solute carrier organic anion transporter family, member 3A1 |
7405 |
0.27 |
chr15_68155525_68155920 | 0.24 |
ENSG00000206625 |
. |
23339 |
0.22 |
chr7_23507368_23507519 | 0.24 |
IGF2BP3 |
insulin-like growth factor 2 mRNA binding protein 3 |
2643 |
0.24 |
chr4_141676823_141677280 | 0.24 |
TBC1D9 |
TBC1 domain family, member 9 (with GRAM domain) |
223 |
0.94 |
chr15_43659707_43659858 | 0.24 |
ZSCAN29 |
zinc finger and SCAN domain containing 29 |
2092 |
0.19 |
chr5_155754238_155754771 | 0.24 |
SGCD |
sarcoglycan, delta (35kDa dystrophin-associated glycoprotein) |
737 |
0.81 |
chr2_109210392_109210708 | 0.24 |
LIMS1 |
LIM and senescent cell antigen-like domains 1 |
5628 |
0.26 |
chr2_230135388_230135942 | 0.24 |
PID1 |
phosphotyrosine interaction domain containing 1 |
316 |
0.93 |
chr4_124339787_124340099 | 0.24 |
SPRY1 |
sprouty homolog 1, antagonist of FGF signaling (Drosophila) |
18820 |
0.3 |
chr4_128553582_128553997 | 0.24 |
INTU |
inturned planar cell polarity protein |
298 |
0.94 |
chr5_73930304_73930586 | 0.24 |
HEXB |
hexosaminidase B (beta polypeptide) |
5403 |
0.23 |
chr1_43672267_43672508 | 0.24 |
ENSG00000199240 |
. |
10299 |
0.15 |
chr10_6980964_6981115 | 0.24 |
PRKCQ |
protein kinase C, theta |
358776 |
0.01 |
chr3_40821863_40822477 | 0.24 |
ZNF621 |
zinc finger protein 621 |
255263 |
0.02 |
chr18_67888672_67888823 | 0.24 |
RTTN |
rotatin |
15566 |
0.25 |
chr8_67454441_67454873 | 0.24 |
ENSG00000206949 |
. |
41111 |
0.13 |
chr4_187765674_187765940 | 0.24 |
ENSG00000252382 |
. |
12803 |
0.3 |
chr1_64240383_64241287 | 0.24 |
ROR1 |
receptor tyrosine kinase-like orphan receptor 1 |
1121 |
0.63 |
chr1_200211795_200211974 | 0.23 |
ENSG00000221403 |
. |
97922 |
0.08 |
chr6_151392247_151392482 | 0.23 |
RP1-292B18.3 |
|
15171 |
0.18 |
chr8_123580850_123581001 | 0.23 |
ENSG00000238901 |
. |
102605 |
0.08 |
chr3_160753082_160753543 | 0.23 |
B3GALNT1 |
beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group) |
65643 |
0.12 |
chr13_103054295_103054752 | 0.23 |
FGF14 |
fibroblast growth factor 14 |
399 |
0.89 |
chrX_70273312_70273567 | 0.23 |
SNX12 |
sorting nexin 12 |
14814 |
0.12 |
chr15_95388341_95388759 | 0.23 |
MCTP2 |
multiple C2 domains, transmembrane 2 |
489347 |
0.01 |
chr11_31006065_31006277 | 0.23 |
DCDC1 |
doublecortin domain containing 1 |
8062 |
0.32 |
chr1_956379_957022 | 0.23 |
AGRN |
agrin |
1197 |
0.27 |
chr5_67640604_67640808 | 0.23 |
PIK3R1 |
phosphoinositide-3-kinase, regulatory subunit 1 (alpha) |
52310 |
0.18 |
chr13_98908140_98908291 | 0.23 |
RP11-573N10.1 |
|
22311 |
0.17 |
chr15_73976688_73977423 | 0.23 |
CD276 |
CD276 molecule |
17 |
0.98 |
chr8_19148668_19149118 | 0.23 |
SH2D4A |
SH2 domain containing 4A |
22235 |
0.28 |
chr13_110958781_110959436 | 0.23 |
COL4A1 |
collagen, type IV, alpha 1 |
370 |
0.6 |
chr17_27567950_27568109 | 0.22 |
CRYBA1 |
crystallin, beta A1 |
5852 |
0.19 |
chr6_94388930_94389081 | 0.22 |
ENSG00000252249 |
. |
199819 |
0.03 |
chr19_54483356_54483962 | 0.22 |
ENSG00000215998 |
. |
1902 |
0.19 |
chr15_99440572_99440803 | 0.22 |
RP11-654A16.1 |
|
3923 |
0.25 |
chr6_84139999_84140706 | 0.22 |
ME1 |
malic enzyme 1, NADP(+)-dependent, cytosolic |
412 |
0.89 |
chr5_121407484_121407781 | 0.22 |
LOX |
lysyl oxidase |
6348 |
0.25 |
chrX_110038687_110039773 | 0.22 |
CHRDL1 |
chordin-like 1 |
56 |
0.99 |
chr6_76234416_76234599 | 0.22 |
FILIP1 |
filamin A interacting protein 1 |
31053 |
0.15 |
chr3_115078299_115078524 | 0.22 |
ZBTB20 |
zinc finger and BTB domain containing 20 |
212293 |
0.02 |
chr7_134893359_134893623 | 0.22 |
WDR91 |
WD repeat domain 91 |
2160 |
0.24 |
chr11_123059250_123059539 | 0.22 |
CTD-2216M2.1 |
|
116 |
0.97 |
chr15_91500342_91500803 | 0.22 |
RCCD1 |
RCC1 domain containing 1 |
1546 |
0.18 |
chr9_112542645_112542955 | 0.22 |
AKAP2 |
A kinase (PRKA) anchor protein 2 |
31 |
0.37 |
chr17_29359724_29359875 | 0.22 |
RP11-271K11.5 |
|
18245 |
0.11 |
chr7_27156991_27157142 | 0.22 |
HOXA-AS2 |
HOXA cluster antisense RNA 2 |
1411 |
0.18 |
chr5_77779952_77780244 | 0.22 |
LHFPL2 |
lipoma HMGIC fusion partner-like 2 |
64876 |
0.13 |
chr1_15354372_15354671 | 0.22 |
KAZN |
kazrin, periplakin interacting protein |
82106 |
0.1 |
chr9_116327712_116328152 | 0.22 |
RGS3 |
regulator of G-protein signaling 3 |
571 |
0.8 |
chr1_23523630_23523879 | 0.22 |
HTR1D |
5-hydroxytryptamine (serotonin) receptor 1D, G protein-coupled |
2532 |
0.23 |
chr15_52298712_52298863 | 0.22 |
MAPK6 |
mitogen-activated protein kinase 6 |
12611 |
0.15 |
chr2_210444017_210444208 | 0.22 |
MAP2 |
microtubule-associated protein 2 |
33 |
0.99 |
chrX_37208613_37209248 | 0.21 |
PRRG1 |
proline rich Gla (G-carboxyglutamic acid) 1 |
298 |
0.54 |
chr15_37348939_37349090 | 0.21 |
ENSG00000206676 |
. |
5883 |
0.25 |
chr15_86018201_86018352 | 0.21 |
AKAP13 |
A kinase (PRKA) anchor protein 13 |
68995 |
0.1 |
chr4_180517206_180517357 | 0.21 |
ENSG00000212191 |
. |
910171 |
0.0 |
chr13_107001311_107002028 | 0.21 |
EFNB2 |
ephrin-B2 |
185793 |
0.03 |
chr4_145566489_145566777 | 0.21 |
HHIP-AS1 |
HHIP antisense RNA 1 |
431 |
0.56 |
chr5_112602506_112602657 | 0.21 |
MCC |
mutated in colorectal cancers |
28065 |
0.22 |
chr3_5699283_5699434 | 0.21 |
ENSG00000241227 |
. |
404450 |
0.01 |
chr8_94937293_94937444 | 0.21 |
PDP1 |
pyruvate dehyrogenase phosphatase catalytic subunit 1 |
5261 |
0.21 |
chr1_206687074_206687508 | 0.21 |
RASSF5 |
Ras association (RalGDS/AF-6) domain family member 5 |
6412 |
0.15 |
chr19_58132756_58132907 | 0.21 |
ZNF134 |
zinc finger protein 134 |
7207 |
0.1 |
chr6_53457738_53458227 | 0.21 |
GCLC |
glutamate-cysteine ligase, catalytic subunit |
23786 |
0.17 |
chr16_1664599_1665551 | 0.21 |
CRAMP1L |
Crm, cramped-like (Drosophila) |
434 |
0.69 |
chr15_71184312_71185443 | 0.21 |
LRRC49 |
leucine rich repeat containing 49 |
88 |
0.55 |
chr6_79315946_79316109 | 0.21 |
IRAK1BP1 |
interleukin-1 receptor-associated kinase 1 binding protein 1 |
261162 |
0.02 |
chr5_155109250_155109533 | 0.21 |
ENSG00000200275 |
. |
163056 |
0.04 |
chr17_53712756_53713118 | 0.21 |
ENSG00000200107 |
. |
83766 |
0.09 |
chr1_11751224_11751616 | 0.21 |
MAD2L2 |
MAD2 mitotic arrest deficient-like 2 (yeast) |
114 |
0.78 |
chr5_123986854_123987468 | 0.21 |
RP11-436H11.2 |
|
77363 |
0.08 |
chr2_216296824_216297216 | 0.21 |
FN1 |
fibronectin 1 |
3770 |
0.26 |
chr7_23513291_23513443 | 0.20 |
IGF2BP3 |
insulin-like growth factor 2 mRNA binding protein 3 |
3281 |
0.22 |
chr4_77357055_77357299 | 0.20 |
SHROOM3 |
shroom family member 3 |
924 |
0.54 |
chr13_113656029_113656238 | 0.20 |
MCF2L |
MCF.2 cell line derived transforming sequence-like |
65 |
0.96 |
chr1_183846597_183846890 | 0.20 |
COLGALT2 |
collagen beta(1-O)galactosyltransferase 2 |
69009 |
0.11 |
chr5_43308499_43308850 | 0.20 |
HMGCS1 |
3-hydroxy-3-methylglutaryl-CoA synthase 1 (soluble) |
4652 |
0.23 |
chr2_208735056_208735207 | 0.20 |
AC083900.1 |
|
492 |
0.83 |
chr14_73929626_73929971 | 0.20 |
ENSG00000251393 |
. |
669 |
0.64 |
chr1_157948474_157948783 | 0.20 |
KIRREL |
kin of IRRE like (Drosophila) |
14435 |
0.21 |
chr17_59273533_59273731 | 0.20 |
RP11-136H19.1 |
|
60307 |
0.12 |
chr7_92460547_92460704 | 0.20 |
CDK6 |
cyclin-dependent kinase 6 |
2606 |
0.31 |
chr3_185533197_185533466 | 0.20 |
IGF2BP2 |
insulin-like growth factor 2 mRNA binding protein 2 |
5518 |
0.25 |
chr18_65598172_65598323 | 0.20 |
DSEL |
dermatan sulfate epimerase-like |
414030 |
0.01 |
chr4_154435359_154435510 | 0.20 |
KIAA0922 |
KIAA0922 |
41614 |
0.18 |
chr7_20372086_20372237 | 0.20 |
CTA-293F17.1 |
|
791 |
0.56 |
chrX_84499187_84500398 | 0.20 |
ZNF711 |
zinc finger protein 711 |
21 |
0.94 |
chr13_37881211_37881446 | 0.20 |
ENSG00000202395 |
. |
140533 |
0.05 |
chr5_131561928_131562079 | 0.20 |
P4HA2 |
prolyl 4-hydroxylase, alpha polypeptide II |
932 |
0.55 |
chr9_37415208_37415514 | 0.20 |
GRHPR |
glyoxylate reductase/hydroxypyruvate reductase |
7302 |
0.19 |
chrX_65857072_65857466 | 0.20 |
EDA2R |
ectodysplasin A2 receptor |
1614 |
0.5 |
chr4_25458860_25459055 | 0.20 |
ANAPC4 |
anaphase promoting complex subunit 4 |
80015 |
0.09 |
chr11_2959193_2959344 | 0.20 |
PHLDA2 |
pleckstrin homology-like domain, family A, member 2 |
8583 |
0.12 |
chr20_35171113_35171392 | 0.20 |
MYL9 |
myosin, light chain 9, regulatory |
1352 |
0.35 |
chr4_183064315_183064489 | 0.20 |
AC108142.1 |
|
527 |
0.65 |
chr17_28562165_28563406 | 0.20 |
SLC6A4 |
solute carrier family 6 (neurotransmitter transporter), member 4 |
69 |
0.95 |
chr11_7599067_7599755 | 0.20 |
PPFIBP2 |
PTPRF interacting protein, binding protein 2 (liprin beta 2) |
1140 |
0.49 |
chr19_31714926_31715193 | 0.20 |
AC020952.1 |
Uncharacterized protein |
74697 |
0.12 |
chr10_76683945_76684144 | 0.20 |
KAT6B |
K(lysine) acetyltransferase 6B |
85586 |
0.08 |
chr9_112402335_112402692 | 0.20 |
PALM2 |
paralemmin 2 |
555 |
0.84 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.4 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.1 | 0.4 | GO:0042686 | negative regulation of heart induction by canonical Wnt signaling pathway(GO:0003136) negative regulation of cardioblast cell fate specification(GO:0009997) cardioblast cell fate commitment(GO:0042684) cardioblast cell fate specification(GO:0042685) regulation of cardioblast cell fate specification(GO:0042686) negative regulation of cardioblast differentiation(GO:0051892) cardiac cell fate specification(GO:0060912) negative regulation of heart induction(GO:1901320) negative regulation of cardiocyte differentiation(GO:1905208) regulation of cardiac cell fate specification(GO:2000043) negative regulation of cardiac cell fate specification(GO:2000044) |
0.1 | 0.1 | GO:0061364 | regulation of negative chemotaxis(GO:0050923) apoptotic process involved in luteolysis(GO:0061364) |
0.1 | 0.3 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.1 | 0.2 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.1 | 0.3 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
0.1 | 0.3 | GO:0045077 | negative regulation of interferon-gamma biosynthetic process(GO:0045077) |
0.1 | 0.3 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.1 | 0.2 | GO:0060058 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.1 | 0.2 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.1 | 0.2 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) 4-hydroxyproline metabolic process(GO:0019471) peptidyl-proline hydroxylation(GO:0019511) |
0.1 | 0.3 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.1 | 0.3 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.1 | 0.2 | GO:0009648 | photoperiodism(GO:0009648) |
0.1 | 0.2 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.1 | 0.2 | GO:0021508 | floor plate formation(GO:0021508) |
0.1 | 0.2 | GO:0002248 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
0.1 | 0.1 | GO:0051176 | positive regulation of sulfur metabolic process(GO:0051176) |
0.0 | 0.3 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.0 | 0.2 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.0 | 0.1 | GO:0032236 | obsolete positive regulation of calcium ion transport via store-operated calcium channel activity(GO:0032236) |
0.0 | 0.0 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
0.0 | 0.2 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.0 | 0.1 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.0 | 0.1 | GO:0010159 | specification of organ position(GO:0010159) |
0.0 | 0.3 | GO:0060039 | pericardium development(GO:0060039) |
0.0 | 0.1 | GO:0022605 | oogenesis stage(GO:0022605) |
0.0 | 0.1 | GO:0007412 | axon target recognition(GO:0007412) |
0.0 | 0.1 | GO:0007500 | mesodermal cell fate determination(GO:0007500) |
0.0 | 0.2 | GO:0008218 | bioluminescence(GO:0008218) |
0.0 | 0.2 | GO:0060536 | trachea cartilage morphogenesis(GO:0060535) cartilage morphogenesis(GO:0060536) |
0.0 | 0.2 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.0 | 0.1 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.0 | 0.1 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
0.0 | 0.2 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
0.0 | 0.3 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.0 | 0.3 | GO:0048703 | embryonic viscerocranium morphogenesis(GO:0048703) |
0.0 | 0.2 | GO:0021794 | thalamus development(GO:0021794) |
0.0 | 0.2 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.0 | 0.1 | GO:0070874 | negative regulation of glycogen metabolic process(GO:0070874) |
0.0 | 0.2 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.0 | 0.3 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.0 | 0.1 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.0 | 0.2 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.0 | 0.3 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.0 | 0.2 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.0 | 0.3 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.0 | 0.3 | GO:0006108 | malate metabolic process(GO:0006108) |
0.0 | 0.1 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
0.0 | 0.1 | GO:0048539 | bone marrow development(GO:0048539) |
0.0 | 0.5 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) |
0.0 | 0.1 | GO:0030219 | megakaryocyte differentiation(GO:0030219) |
0.0 | 0.4 | GO:0070373 | negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
0.0 | 0.1 | GO:0016266 | O-glycan processing(GO:0016266) |
0.0 | 0.1 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.0 | 0.1 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
0.0 | 0.3 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.0 | 0.1 | GO:0010837 | regulation of keratinocyte proliferation(GO:0010837) |
0.0 | 0.1 | GO:0001547 | antral ovarian follicle growth(GO:0001547) |
0.0 | 0.1 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) protein O-linked glycosylation via threonine(GO:0018243) |
0.0 | 0.1 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.0 | 0.1 | GO:0050942 | positive regulation of melanocyte differentiation(GO:0045636) positive regulation of pigment cell differentiation(GO:0050942) |
0.0 | 0.1 | GO:0060242 | contact inhibition(GO:0060242) |
0.0 | 0.2 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.0 | 0.8 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
0.0 | 0.2 | GO:0045652 | regulation of megakaryocyte differentiation(GO:0045652) regulation of hematopoietic progenitor cell differentiation(GO:1901532) |
0.0 | 0.1 | GO:0021892 | cerebral cortex GABAergic interneuron differentiation(GO:0021892) |
0.0 | 0.1 | GO:1903170 | negative regulation of ion transmembrane transporter activity(GO:0032413) negative regulation of release of sequestered calcium ion into cytosol(GO:0051280) positive regulation of sequestering of calcium ion(GO:0051284) negative regulation of calcium ion transmembrane transport(GO:1903170) |
0.0 | 0.1 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.0 | 0.1 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.0 | 0.1 | GO:0048343 | paraxial mesodermal cell differentiation(GO:0048342) paraxial mesodermal cell fate commitment(GO:0048343) |
0.0 | 0.1 | GO:0008049 | male courtship behavior(GO:0008049) |
0.0 | 0.1 | GO:0097435 | extracellular fibril organization(GO:0043206) fibril organization(GO:0097435) |
0.0 | 0.1 | GO:0072048 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) pattern specification involved in metanephros development(GO:0072268) |
0.0 | 0.1 | GO:0060737 | prostate gland morphogenetic growth(GO:0060737) |
0.0 | 0.0 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
0.0 | 0.0 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.0 | 0.2 | GO:0000052 | citrulline metabolic process(GO:0000052) |
0.0 | 0.0 | GO:0061318 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.0 | 0.2 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.0 | 0.0 | GO:0032278 | positive regulation of gonadotropin secretion(GO:0032278) positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
0.0 | 0.1 | GO:0003214 | cardiac left ventricle morphogenesis(GO:0003214) |
0.0 | 0.0 | GO:0060426 | lung vasculature development(GO:0060426) |
0.0 | 0.1 | GO:0008228 | opsonization(GO:0008228) |
0.0 | 0.2 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.0 | 0.1 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
0.0 | 0.1 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
0.0 | 0.1 | GO:0033194 | response to hydroperoxide(GO:0033194) |
0.0 | 0.2 | GO:0008347 | glial cell migration(GO:0008347) |
0.0 | 0.2 | GO:0048048 | embryonic eye morphogenesis(GO:0048048) |
0.0 | 0.1 | GO:0060736 | prostate gland growth(GO:0060736) |
0.0 | 0.1 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.0 | 0.0 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
0.0 | 0.1 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.0 | 0.1 | GO:0006154 | adenosine catabolic process(GO:0006154) |
0.0 | 0.0 | GO:1903960 | negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) negative regulation of anion transmembrane transport(GO:1903960) negative regulation of fatty acid transport(GO:2000192) |
0.0 | 0.2 | GO:0031000 | response to caffeine(GO:0031000) |
0.0 | 0.1 | GO:1900116 | sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.0 | 0.1 | GO:0045425 | positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045425) |
0.0 | 0.1 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.0 | 0.1 | GO:0050686 | negative regulation of mRNA processing(GO:0050686) negative regulation of mRNA metabolic process(GO:1903312) |
0.0 | 0.1 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.0 | 0.1 | GO:0051124 | synaptic growth at neuromuscular junction(GO:0051124) |
0.0 | 0.1 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.0 | 0.1 | GO:0008215 | spermine metabolic process(GO:0008215) |
0.0 | 0.0 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.0 | 0.1 | GO:0015889 | cobalamin transport(GO:0015889) |
0.0 | 0.1 | GO:0051451 | myoblast migration(GO:0051451) |
0.0 | 0.1 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
0.0 | 0.1 | GO:0060638 | mesenchymal-epithelial cell signaling(GO:0060638) |
0.0 | 0.0 | GO:0071605 | monocyte chemotactic protein-1 production(GO:0071605) regulation of monocyte chemotactic protein-1 production(GO:0071637) |
0.0 | 0.1 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.0 | 0.1 | GO:1903318 | negative regulation of protein processing(GO:0010955) negative regulation of protein maturation(GO:1903318) |
0.0 | 0.0 | GO:2000178 | negative regulation of neuroblast proliferation(GO:0007406) negative regulation of neural precursor cell proliferation(GO:2000178) |
0.0 | 0.0 | GO:0033197 | response to vitamin E(GO:0033197) |
0.0 | 0.1 | GO:0002551 | mast cell chemotaxis(GO:0002551) regulation of mast cell chemotaxis(GO:0060753) positive regulation of mast cell chemotaxis(GO:0060754) mast cell migration(GO:0097531) |
0.0 | 0.3 | GO:0008038 | neuron recognition(GO:0008038) |
0.0 | 0.0 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
0.0 | 0.0 | GO:0010799 | regulation of peptidyl-threonine phosphorylation(GO:0010799) |
0.0 | 0.0 | GO:0060677 | ureteric bud elongation(GO:0060677) |
0.0 | 0.0 | GO:0048319 | axial mesoderm development(GO:0048318) axial mesoderm morphogenesis(GO:0048319) |
0.0 | 0.0 | GO:0032328 | alanine transport(GO:0032328) |
0.0 | 0.0 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
0.0 | 0.0 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.0 | 0.3 | GO:0033138 | positive regulation of peptidyl-serine phosphorylation(GO:0033138) |
0.0 | 0.0 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.0 | 0.3 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
0.0 | 0.1 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.0 | 0.0 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.0 | 0.0 | GO:0031223 | auditory behavior(GO:0031223) |
0.0 | 0.1 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.0 | 0.1 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.0 | 0.2 | GO:0046697 | decidualization(GO:0046697) |
0.0 | 0.0 | GO:0060174 | limb bud formation(GO:0060174) |
0.0 | 0.0 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.0 | 0.1 | GO:0010107 | potassium ion import(GO:0010107) |
0.0 | 0.0 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.0 | 0.0 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.0 | 0.0 | GO:0046010 | positive regulation of circadian sleep/wake cycle, non-REM sleep(GO:0046010) |
0.0 | 0.0 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.0 | 0.3 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.0 | 0.0 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.0 | 0.0 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.0 | 0.1 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
0.0 | 0.1 | GO:0051931 | regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
0.0 | 0.0 | GO:0014824 | tonic smooth muscle contraction(GO:0014820) artery smooth muscle contraction(GO:0014824) |
0.0 | 0.0 | GO:0021591 | ventricular system development(GO:0021591) |
0.0 | 0.1 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.0 | 0.0 | GO:0071379 | cellular response to prostaglandin stimulus(GO:0071379) |
0.0 | 0.1 | GO:0001660 | fever generation(GO:0001660) |
0.0 | 0.0 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.0 | 0.0 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of calcium ion transmembrane transporter activity(GO:1901021) regulation of store-operated calcium channel activity(GO:1901339) positive regulation of store-operated calcium channel activity(GO:1901341) positive regulation of cation channel activity(GO:2001259) |
0.0 | 0.1 | GO:0035329 | hippo signaling(GO:0035329) |
0.0 | 0.0 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.0 | 0.1 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
0.0 | 0.0 | GO:0072162 | mesenchymal cell differentiation involved in kidney development(GO:0072161) metanephric mesenchymal cell differentiation(GO:0072162) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.0 | 0.1 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.0 | 0.0 | GO:0021615 | glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
0.0 | 0.1 | GO:0061081 | positive regulation of myeloid leukocyte cytokine production involved in immune response(GO:0061081) |
0.0 | 0.0 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.0 | 0.1 | GO:0043113 | receptor clustering(GO:0043113) |
0.0 | 0.0 | GO:2000400 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
0.0 | 0.0 | GO:0042339 | keratan sulfate metabolic process(GO:0042339) |
0.0 | 0.0 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) negative regulation of signal transduction by p53 class mediator(GO:1901797) |
0.0 | 0.4 | GO:0060606 | neural tube closure(GO:0001843) tube closure(GO:0060606) |
0.0 | 0.1 | GO:0021571 | rhombomere 5 development(GO:0021571) |
0.0 | 0.1 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.0 | 0.0 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.0 | 0.2 | GO:0042554 | superoxide anion generation(GO:0042554) |
0.0 | 0.0 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.0 | 0.0 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
0.0 | 0.0 | GO:0060251 | regulation of glial cell proliferation(GO:0060251) |
0.0 | 0.0 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.0 | 0.1 | GO:0035412 | catenin import into nucleus(GO:0035411) regulation of catenin import into nucleus(GO:0035412) |
0.0 | 0.1 | GO:0042220 | response to cocaine(GO:0042220) |
0.0 | 0.1 | GO:0015074 | DNA integration(GO:0015074) |
0.0 | 0.0 | GO:0031650 | regulation of heat generation(GO:0031650) positive regulation of heat generation(GO:0031652) |
0.0 | 0.1 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.0 | 0.0 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) maturation of LSU-rRNA(GO:0000470) |
0.0 | 0.0 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) regulation of dendritic spine morphogenesis(GO:0061001) dendritic spine organization(GO:0097061) |
0.0 | 0.0 | GO:0090085 | regulation of protein deubiquitination(GO:0090085) |
0.0 | 0.0 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
0.0 | 0.0 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.0 | 0.0 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.0 | 0.0 | GO:0002686 | negative regulation of leukocyte migration(GO:0002686) |
0.0 | 0.2 | GO:0045104 | intermediate filament cytoskeleton organization(GO:0045104) |
0.0 | 0.0 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.0 | 0.0 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
0.0 | 0.1 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.0 | 0.0 | GO:0070091 | glucagon secretion(GO:0070091) regulation of glucagon secretion(GO:0070092) |
0.0 | 0.0 | GO:0035067 | negative regulation of histone acetylation(GO:0035067) negative regulation of protein acetylation(GO:1901984) negative regulation of peptidyl-lysine acetylation(GO:2000757) |
0.0 | 0.0 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.0 | 0.0 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.0 | 0.0 | GO:0032344 | regulation of ketone biosynthetic process(GO:0010566) regulation of aldosterone metabolic process(GO:0032344) regulation of aldosterone biosynthetic process(GO:0032347) |
0.0 | 0.0 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.0 | 0.0 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.0 | 0.0 | GO:0019348 | polyprenol metabolic process(GO:0016093) dolichol metabolic process(GO:0019348) |
0.0 | 0.1 | GO:0015884 | folic acid transport(GO:0015884) |
0.0 | 0.0 | GO:2000050 | regulation of non-canonical Wnt signaling pathway(GO:2000050) regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.0 | 0.0 | GO:2000649 | regulation of sodium:proton antiporter activity(GO:0032415) regulation of sodium ion transmembrane transport(GO:1902305) regulation of sodium ion transmembrane transporter activity(GO:2000649) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.4 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.1 | 0.3 | GO:0070852 | cell body fiber(GO:0070852) |
0.1 | 0.4 | GO:0098642 | network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) |
0.0 | 0.3 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.0 | 0.1 | GO:0060200 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
0.0 | 0.3 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 0.1 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
0.0 | 0.2 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.0 | 0.1 | GO:0043260 | laminin-11 complex(GO:0043260) |
0.0 | 0.2 | GO:0031512 | motile primary cilium(GO:0031512) |
0.0 | 0.3 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.0 | 0.1 | GO:0030904 | retromer complex(GO:0030904) |
0.0 | 0.1 | GO:0001940 | male pronucleus(GO:0001940) |
0.0 | 0.3 | GO:0043034 | costamere(GO:0043034) |
0.0 | 0.2 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.0 | 0.0 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.0 | 0.1 | GO:0030056 | hemidesmosome(GO:0030056) |
0.0 | 0.1 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 0.1 | GO:0001527 | microfibril(GO:0001527) |
0.0 | 0.1 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.0 | 0.1 | GO:0030673 | axolemma(GO:0030673) |
0.0 | 0.1 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.0 | 0.1 | GO:0045277 | mitochondrial respiratory chain complex IV(GO:0005751) respiratory chain complex IV(GO:0045277) |
0.0 | 0.1 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.0 | 0.2 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.0 | 0.1 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.0 | 0.1 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.0 | 0.2 | GO:0005858 | axonemal dynein complex(GO:0005858) |
0.0 | 0.1 | GO:0070552 | BRISC complex(GO:0070552) |
0.0 | 0.1 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.0 | 0.1 | GO:0043218 | compact myelin(GO:0043218) |
0.0 | 0.1 | GO:0005678 | obsolete chromatin assembly complex(GO:0005678) |
0.0 | 0.0 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.0 | 1.0 | GO:0014069 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
0.0 | 0.0 | GO:0014704 | intercalated disc(GO:0014704) cell-cell contact zone(GO:0044291) |
0.0 | 0.1 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.0 | 0.0 | GO:0032449 | CBM complex(GO:0032449) |
0.0 | 0.0 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.0 | 0.1 | GO:0005915 | zonula adherens(GO:0005915) |
0.0 | 0.2 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.0 | 0.0 | GO:0070545 | PeBoW complex(GO:0070545) |
0.0 | 2.8 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 0.0 | GO:0043083 | synaptic cleft(GO:0043083) |
0.0 | 0.6 | GO:0030426 | growth cone(GO:0030426) |
0.0 | 0.1 | GO:0030897 | HOPS complex(GO:0030897) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.5 | GO:0001099 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
0.1 | 0.3 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.1 | 0.3 | GO:0004470 | malic enzyme activity(GO:0004470) |
0.1 | 0.2 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) acyl-CoA desaturase activity(GO:0016215) |
0.1 | 0.3 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.1 | 0.4 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
0.1 | 0.2 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.1 | 1.0 | GO:0043394 | proteoglycan binding(GO:0043394) |
0.1 | 0.4 | GO:0042153 | obsolete RPTP-like protein binding(GO:0042153) |
0.1 | 0.2 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.1 | 0.2 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.1 | 0.2 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
0.1 | 0.2 | GO:0031545 | procollagen-proline 4-dioxygenase activity(GO:0004656) peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.1 | 0.3 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.1 | 0.2 | GO:0070215 | obsolete MDM2 binding(GO:0070215) |
0.1 | 0.2 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
0.1 | 0.2 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.1 | 0.3 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.1 | 0.2 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.0 | 0.2 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.0 | 0.1 | GO:0048495 | Roundabout binding(GO:0048495) |
0.0 | 0.2 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.0 | 0.1 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.0 | 0.3 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.0 | 0.2 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.0 | 0.1 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
0.0 | 0.2 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.0 | 0.2 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.0 | 0.3 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.0 | 0.1 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.0 | 0.2 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.0 | 0.2 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.0 | 0.1 | GO:0030172 | troponin C binding(GO:0030172) |
0.0 | 0.1 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.0 | 0.1 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
0.0 | 0.1 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.0 | 0.1 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.0 | 0.1 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.0 | 0.3 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.0 | 0.1 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
0.0 | 0.3 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.0 | 0.2 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.0 | 0.1 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.0 | 0.5 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.0 | 0.3 | GO:0001968 | fibronectin binding(GO:0001968) |
0.0 | 0.1 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.0 | 0.1 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.0 | 0.2 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.0 | 0.1 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.0 | 0.1 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.0 | 0.1 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.0 | 0.1 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.0 | 0.2 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.0 | 0.3 | GO:0030553 | cGMP binding(GO:0030553) |
0.0 | 0.1 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.0 | 0.1 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
0.0 | 0.1 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.0 | 0.1 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.0 | 0.3 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.0 | 0.1 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.0 | 0.0 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.0 | 0.1 | GO:0042805 | actinin binding(GO:0042805) |
0.0 | 0.6 | GO:0005518 | collagen binding(GO:0005518) |
0.0 | 0.1 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
0.0 | 0.1 | GO:0045545 | syndecan binding(GO:0045545) |
0.0 | 0.1 | GO:0009374 | biotin binding(GO:0009374) |
0.0 | 0.4 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.0 | GO:0043559 | insulin binding(GO:0043559) |
0.0 | 0.1 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.0 | 0.1 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.0 | 0.1 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.0 | 0.1 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.0 | 0.1 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.0 | 0.1 | GO:0016362 | activin receptor activity, type II(GO:0016362) |
0.0 | 0.2 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.0 | 0.1 | GO:0035198 | miRNA binding(GO:0035198) |
0.0 | 0.1 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.0 | 0.4 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.0 | 0.1 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.0 | 0.1 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.0 | 0.0 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.0 | 0.1 | GO:0030507 | spectrin binding(GO:0030507) |
0.0 | 0.0 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.0 | 0.1 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.0 | 0.0 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.0 | 0.1 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.0 | 0.1 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.0 | 0.1 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.0 | 0.0 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.0 | 0.0 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.0 | 0.1 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.0 | 0.2 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.0 | 0.1 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 0.3 | GO:0050699 | WW domain binding(GO:0050699) |
0.0 | 0.0 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.0 | 0.1 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.0 | 0.2 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.0 | 0.0 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.0 | 0.0 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.0 | 0.0 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.0 | 0.1 | GO:0019841 | retinol binding(GO:0019841) |
0.0 | 0.1 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.0 | 0.1 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.0 | 0.1 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.0 | 0.0 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.0 | 0.0 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.0 | 0.0 | GO:0031708 | bombesin receptor binding(GO:0031705) endothelin B receptor binding(GO:0031708) |
0.0 | 0.0 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.0 | 0.3 | GO:0070330 | aromatase activity(GO:0070330) |
0.0 | 0.1 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.0 | 0.1 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.0 | 0.2 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.0 | 0.0 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.0 | 0.2 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.0 | 0.0 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.0 | 0.1 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.0 | 0.0 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.0 | 0.1 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.0 | 0.0 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.0 | 0.0 | GO:0033765 | steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) |
0.0 | 0.1 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.0 | 0.1 | GO:0008430 | selenium binding(GO:0008430) |
0.0 | 0.0 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.0 | 0.1 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.0 | 0.1 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.0 | 0.4 | GO:0008307 | structural constituent of muscle(GO:0008307) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.1 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 0.1 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.0 | 0.5 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 0.3 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.0 | 0.2 | PID ALK2 PATHWAY | ALK2 signaling events |
0.0 | 0.7 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.0 | 0.6 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.0 | 0.1 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.0 | 0.0 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.0 | 0.6 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 0.1 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.0 | 0.0 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.0 | 0.5 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.0 | 0.3 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 0.1 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.0 | 0.1 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.0 | 0.2 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 1.9 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.1 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.0 | 0.1 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.0 | 0.5 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.0 | 0.0 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.0 | 0.1 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.0 | 0.1 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.0 | 0.3 | NABA CORE MATRISOME | Ensemble of genes encoding core extracellular matrix including ECM glycoproteins, collagens and proteoglycans |
0.0 | 0.1 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 1.3 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.0 | 0.3 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.0 | 0.7 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 0.1 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.0 | 0.7 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.5 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 0.8 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 0.5 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.0 | 0.3 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.0 | 0.2 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.0 | 0.1 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.0 | 0.2 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.0 | 0.3 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.0 | 0.1 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.0 | 0.1 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.0 | 0.3 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 0.2 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.0 | 0.3 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.0 | 0.1 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 0.2 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.0 | 0.0 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.0 | 0.1 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.0 | 0.2 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.0 | 0.0 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.0 | 0.2 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 0.0 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.0 | 0.0 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.0 | 0.0 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.0 | 0.1 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.0 | 0.1 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.0 | 0.1 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.0 | 0.0 | REACTOME MAPK TARGETS NUCLEAR EVENTS MEDIATED BY MAP KINASES | Genes involved in MAPK targets/ Nuclear events mediated by MAP kinases |
0.0 | 0.1 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 0.1 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.0 | 0.2 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |